Updated:
UroPartners
UroPartners is a network of physician practices in Des Plaines, Illinois, specializing in urology. The company offers urologic care services including...
UroPartners
UroPartners is a network of physician practices in Des Plaines, Illinois, specializing in urology. The company offers urologic care services including diagnosis and treatment of urological disorders, pathology lab services, and radiation oncology. UroPartners serves patients with conditions such as prostate cancer and benign prostatic hyperplasia.
General information
Firm type
null
Location
Region
North America
Country
null
City
null
Corporate office
null
Sector focus
Frequently asked questions
Who runs investment decisions at UroPartners?
UroPartners does not publicly disclose its investment leadership. The management team likely includes healthcare executives and physicians, but names are not available from public sources.
How does UroPartners source proprietary deal flow?
The firm likely sources deals through direct relationships with independent urology practices seeking consolidation. As a specialty-focused entity, it may also attract referrals from practice valuations or industry conferences.
What investment stages does UroPartners typically target?
UroPartners appears focused on acquiring mature, independent urology practices rather than early-stage startups. This is consistent with a roll-up strategy in established healthcare services.
Does UroPartners participate in fund commitments or only direct deals?
Public records suggest UroPartners operates through direct acquisitions of physician practices. There is no evidence of fund commitments to external managers.
Which sectors does UroPartners explicitly avoid?
By stated focus on urology, the firm avoids general healthcare services outside its specialty. No formal avoidance list is published.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: